Cerapedics' i-Factor+ Matrix is now available for surgical implantation in Canada.
Surgi-One will distribute the product, which is cleared for use in spine and general orthopedic procedures, the orthobiologics company said in a Nov. 5 news release.
I-Factor+ Matrix uses a peptide technology to promote bone growth through cell attraction, attachment and activation.
The FDA is evaluating the product in an investigational device exemption study for lumbar fusions.
I-Factor+ Matrix has not been approved for use in the U.S.